AD progression at the histopathological level is associated with chronic activation of IRE1α in the brain, and IRE1α deficiency significantly reduces the accumulation of Aβ in the brain of 5xFAD mice (Duran-Aniotz et al., 2017). This evidence concerns the gene ERN1 and Alzheimer disease.